Theseus Pharmaceuticals, Inc. (THRX) Social Stream



Theseus Pharmaceuticals, Inc. (THRX): $5.98

0.28 (+4.91%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add THRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Theseus Pharmaceuticals Inc (THRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Theseus Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-17 4 $28 $23 $25 $11.72 113.31%
2022-03-11 4 $25 $18 $22.5 $11.72 91.98%

THRX reports an average of 73.96% for its upside potential over the past 130 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-01 4 28 23 25.0 17.13 45.94%
2021-11-16 4 28 23 25.0 17.28 44.68%
2021-11-17 4 28 23 25.0 18.55 34.77%
2022-02-08 4 25 18 22.5 10.58 112.67%
2022-03-11 4 25 18 22.5 9.71 131.72%

THRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Theseus Pharmaceuticals Inc's number of analysts covering the stock is higher than 38.1% of them.
  • Theseus Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 155.66% of all US stocks.
  • Theseus Pharmaceuticals Inc's variance in analysts' estimates is lower than 60.79% of Pharmaceutical Products stocks.
  • Theseus Pharmaceuticals Inc's average analyst price target is greater than 75.94% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Theseus Pharmaceuticals Inc are THRN, TFFP, and TERN.

Make investment decisions regarding THRX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4887 seconds.